← Leaderboards
Kevin Sill
Intezyne Technologies, Llc
$1,132,200
Attributed
$1,132,200
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $945K · FY2012–14$1M$750K$500K$250K$0
'12
'13
'14
Funding mix
By agency
NIH$1,132,200 · 2
By mechanism
N44$944,978 · 1
N43$187,222 · 1
Top collaborators
No co-investigators on record.
Most similar at Intezyne Technologies, Llc
Same institution · by research overlap
- Kevin N Sill$296,455
Others in their field
Top investigators on “Drug Formulations”
- David Heimbrook · Leidos Biomedical Research, Inc.$143,562,560
- Sharon A Nachman · Johns Hopkins University$135,132,510
- Jaap Goudsmit · Janessen Vaccines And Prevention, Bv$70,218,020
- Thomas Macvittie · University Of Maryland Baltimore$64,108,499
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Polly Chang · Sri International$60,528,575
Research focus
Drug FormulationsMicellesPharmaceutical PreparationsDrug KineticsPolymersEncapsulatedXenograft ModelChemistryClinical TrialsComparative EfficacyCrosslinkCytotoxicityDoseEpothilone BEpothilone DExhibitsIntravenousIn VitroIn VivoIronLeadMalignant NeoplasmsMaximum Tolerated DoseNanoparticle